Blog
RSS FeedPosted by Michael Wonder on 27 Mar 2025
ViiV Healthcare announces reimbursement for Apretude for HIV-1 pre-exposure prophylaxis under the Non-Insured Health Benefits (NIHB) Program
25 March 2025 - ViiV Healthcare is pleased to announce that Apretude (cabotegravir tablets and extended release injectable suspension) is ...
Posted by Michael Wonder on 27 Mar 2025
American pharmaceutical boss does not support tariffs on Australian medicines
26 March 2025 - The head of one of America's largest pharmaceutical companies says he does not support tariffs on ...
Posted by Michael Wonder on 27 Mar 2025
New and expanded cheaper medicines
27 March 2025 - Australians with Cushing’s syndrome, retinal vein occlusion and psoriatic arthritis, leukaemia, and women needing contraception and menopause ...
Posted by Michael Wonder on 25 Mar 2025
Government of Canada signs bilateral agreement with Quebec for Drugs for Rare Diseases
21 March 2025 - In Canada, one in 12 people live with a rare disease, and for most people affected, the ...
Posted by Michael Wonder on 21 Mar 2025
Public Summary Documents (first time rejections and deferrals)– November 2024 PBAC meeting
21 March 2025 - The Public Summary Documents (first time decisions not to recommend and deferrals) from the November 2024 PBAC ...
Posted by Michael Wonder on 21 Mar 2025
Strengthening Medicare: cheaper medicines to get even cheaper
20 March 2025 - The Albanese Labor Government is making cheaper medicines even cheaper – with a script to cost ...
Posted by Michael Wonder on 21 Mar 2025
Why US drug giants are so angry about Australia’s PBS
20 March 2025 - US pharmaceutical giants hope the protectionist Trump administration will force Australia to increase the price it pays ...
Posted by Michael Wonder on 20 Mar 2025
PBS medication to cost no more than $25 under Labor re-election pitch
19 March 2025 - Australians are set to save a combined $200 million a year under the plan, which will cost ...
Posted by Michael Wonder on 20 Mar 2025
Australia defends PBS as US companies urge Trump to impose reciprocal tariffs
19 March 2025 - American medical giants have labelled the federal government's PBS "egregious and discriminatory" and have pressed US ...
Posted by Michael Wonder on 20 Mar 2025
Big pharma’s plea to Trump to punish Australia for cheaper medicines
19 March 2025 - American medical giants have slammed the $18 billion pharmaceutical benefits scheme in a plea to US ...
Posted by Michael Wonder on 19 Mar 2025
Linzagolix choline in endometriosis: comparative data are lacking
18 March 2025 - There are no comparative studies with established active ingredients in endometriosis; placebo comparisons are unsuitable for assessing ...
Posted by Michael Wonder on 17 Mar 2025
Government delivering even more choice for women's contraception, endometriosis, and IVF journeys
16 March 2025 - The Government is delivering even more choice for Australian women with new and amended listings for contraception, ...
Posted by Michael Wonder on 14 Mar 2025
DUSC utilisation analysis public release documents (October 2024)
14 March 2025 - The utilisation analysis public release documents from the October 2024 DUSC meeting are now available. ...
Posted by Michael Wonder on 13 Mar 2025
First licensed treatment for ultra-rare immune disorder recommended
13 March 2025 - Leniolisib is the first ever treatment for activated phosphoinositide 3-kinase delta syndrome licensed for use in the ...
Posted by Michael Wonder on 13 Mar 2025
First daily pill for endometriosis approved for NHS use
13 March 2025 - Today we've recommended the first long-term daily pill to treat endometriosis that could transform how this painful ...